- Home
- FR vs RVMD Comparison
FR vs RVMD Comparison
Compare FR & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FR
- RVMD
- Stock Information
- Founded
- FR 1993
- RVMD 2014
- Country
- FR United States
- RVMD United States
- Employees
- FR N/A
- RVMD N/A
- Industry
- FR Real Estate Investment Trusts
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FR Real Estate
- RVMD Health Care
- Exchange
- FR Nasdaq
- RVMD Nasdaq
- Market Cap
- FR 7.4B
- RVMD 7.5B
- IPO Year
- FR 1994
- RVMD 2020
- Fundamental
- Price
- FR $57.85
- RVMD $77.98
- Analyst Decision
- FR Buy
- RVMD Strong Buy
- Analyst Count
- FR 11
- RVMD 18
- Target Price
- FR $57.00
- RVMD $77.11
- AVG Volume (30 Days)
- FR 818.2K
- RVMD 2.5M
- Earning Date
- FR 10-15-2025
- RVMD 11-05-2025
- Dividend Yield
- FR 3.09%
- RVMD N/A
- EPS Growth
- FR N/A
- RVMD N/A
- EPS
- FR 1.79
- RVMD N/A
- Revenue
- FR $714,032,000.00
- RVMD N/A
- Revenue This Year
- FR $11.21
- RVMD N/A
- Revenue Next Year
- FR $7.45
- RVMD $537.73
- P/E Ratio
- FR $32.16
- RVMD N/A
- Revenue Growth
- FR 8.93
- RVMD N/A
- 52 Week Low
- FR $40.31
- RVMD $29.17
- 52 Week High
- FR $58.17
- RVMD $78.17
- Technical
- Relative Strength Index (RSI)
- FR 69.04
- RVMD 87.81
- Support Level
- FR $54.52
- RVMD $69.50
- Resistance Level
- FR $56.13
- RVMD $72.72
- Average True Range (ATR)
- FR 0.96
- RVMD 2.65
- MACD
- FR 0.05
- RVMD 0.73
- Stochastic Oscillator
- FR 95.11
- RVMD 98.73
About FR First Industrial Realty Trust Inc.
First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.